S-1-based concurrent chemoradiotherapy in the treatment of locally advanced non-small cell lung cancer: A systematic review and meta-analysis protocol

BACKGROUND: Lung cancer is the leading cause of cancer-related deaths in the world, and non-small cell lung cancer accounts for > 75% of all lung cancer cases. Cisplatin-based concurrent chemoradiotherapy has become the standard treatment for locally advanced non-small cell lung cancer (NSCLC). T...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Feiyu, Wang, Chaoyang, Hu, Tao, Wang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908622/
https://www.ncbi.nlm.nih.gov/pubmed/29642202
http://dx.doi.org/10.1097/MD.0000000000010397

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908622/
https://www.ncbi.nlm.nih.gov/pubmed/29642202
http://dx.doi.org/10.1097/MD.0000000000010397

Ejemplares similares